These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 2288719)

  • 1. Rationales for combining chemotherapy and biotherapy in the treatment of cancer.
    Dillman RO
    Mol Biother; 1990 Dec; 2(4):201-7. PubMed ID: 2288719
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antineoplastic activity of the combination of interferon and cytotoxic agents against experimental and human malignancies: a review.
    Wadler S; Schwartz EL
    Cancer Res; 1990 Jun; 50(12):3473-86. PubMed ID: 1692761
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New approaches to the systemic treatment of melanoma.
    Chowdhury S; Vaughan MM; Gore ME
    Cancer Treat Rev; 1999 Oct; 25(5):259-70. PubMed ID: 10544070
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adjuvant and neoadjuvant therapy for gastric cancer.
    Kelsen DP
    Semin Oncol; 1996 Jun; 23(3):379-89. PubMed ID: 8658222
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combination of chemotherapy with interleukin-2 and interferon-alfa for the treatment of advanced melanoma.
    Buzaid AC; Legha SS
    Semin Oncol; 1994 Dec; 21(6 Suppl 14):23-8. PubMed ID: 7992096
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bio-immunotherapy for cancer in experimental studies and clinical application: current status and future challenges.
    Shen RN; Lu L; Kaiser HE; Broxmeyer HE
    In Vivo; 1994; 8(5):643-52. PubMed ID: 7727711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Chemo-signal therapy, an emerging new approach to modify drug resistance in breast cancer.
    Pusztai L; Esteva FJ; Cristofanilli M; Hung MC; Hortobagyi GN
    Cancer Treat Rev; 1999 Oct; 25(5):271-7. PubMed ID: 10544071
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Design of combination biotherapy studies: future goals and challenges.
    Gilewski TA; Golomb HM
    Semin Oncol; 1990 Feb; 17(1 Suppl 1):3-10; discussion 38-41. PubMed ID: 1689077
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple dietary antioxidants enhance the efficacy of standard and experimental cancer therapies and decrease their toxicity.
    Prasad KN
    Integr Cancer Ther; 2004 Dec; 3(4):310-22. PubMed ID: 15523102
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunological approach in the diagnosis, therapy and prognosis of the exocrine pancreatic cancer.
    Bădulescu F; Bădulescu A; Rogoz S; Mustaţă R
    Roum Arch Microbiol Immunol; 2001; 60(1):5-16. PubMed ID: 11850897
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Activated CD4+ T cells dramatically enhance chemotherapeutic tumor responses in vitro and in vivo.
    Radfar S; Wang Y; Khong HT
    J Immunol; 2009 Nov; 183(10):6800-7. PubMed ID: 19846868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Systemic treatment of malignant melanoma.
    Mota A; Deisseroth A
    Clin Plast Surg; 2000 Jul; 27(3):463-74, x. PubMed ID: 10941566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The repetitive immune cell transfer therapy combining non-myelosuppressive chemotherapy for patients with advanced and refractory cancer].
    Toh U; Fujii T; Tayama K; Yanaga H; Yokoyama G; Yamaguchi M; Horiuchi H; Sasatomi T; Takamori S; Shirouzu K; Seki N; Yamana H
    Gan To Kagaku Ryoho; 2004 Oct; 31(11):1649-51. PubMed ID: 15553672
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer treatment: what's ahead?
    Parvez T
    J Coll Physicians Surg Pak; 2005 Nov; 15(11):738-45. PubMed ID: 16300718
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Shi-quan-da-bu-tang (ten significant tonic decoction), SQT. A potent Chinese biological response modifier in cancer immunotherapy, potentiation and detoxification of anticancer drugs.
    Zee-Cheng RK
    Methods Find Exp Clin Pharmacol; 1992 Nov; 14(9):725-36. PubMed ID: 1294861
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunotherapy for prostate cancer - recent progress in clinical trials.
    Kipp RT; McNeel DG
    Clin Adv Hematol Oncol; 2007 Jun; 5(6):465-74, 477-9. PubMed ID: 17679921
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy for metastatic melanoma.
    Mandarà M; Nortilli R; Sava T; Cetto GL
    Expert Rev Anticancer Ther; 2006 Jan; 6(1):121-30. PubMed ID: 16375649
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Overview of biotherapy and nursing considerations.
    Coleman C
    J Intraven Nurs; 1998; 21(6):367-73. PubMed ID: 10392103
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.